Here are the comprehensive details for the Chemkart India Limited IPO:
IPO Timeline
- Offer Opens: July 7, 2025
- Offer Closes: July 9, 2025
- Allotment Finalized: July 10, 2025 (refund 11th, shares credited)
- Initiation of Refunds: Jul 11, 2025
- Credit of Shares to Demat: Jul 11, 2025
- Expected Listing: July 14, 2025 on BSE SME platform
IPO Details
- Face Value: ₹10 per share
- Price Band: ₹236 – ₹248 per share (~23.6–24.8 × face value ₹10)
- Lot Size: 600 shares (~₹1.41 lakh per lot at floor price)
- Minimum Application: 2 lots (1,200 shares) ≈ ₹2.83–2.97 lakh depending on share price
- Total Issue Size: 32,29,200 shares
- Fresh Issue: 24,33,800 shares
- Issue Type: Bookbuilding IPO
- Listing At: BSE SME
- Share Holding Pre Issue: 94,99,000 shares
- Share Holding Post Issue: 1,20,99,000 shares
GMP of Chemkart India Limited IPO
As of July 3, 2025, the Grey Market Premium (GMP) for the Chemkart India Limited IPO stands at ₹0, indicating no unofficial premium over the issue price in the grey market.
Promoters of Chemkart India Limited
Here are the key details about the promoters of Chemkart India Limited:
1. Mr. Ankit Shailesh Mehta – Chairman & Managing Director
- Age: 34 years
- Education: B.Tech in Chemical Engineering & MBA in Technology Management from Mukesh Patel School of Technology Management & Engineering
Professional Experience:
- Designated Partner at Tuvan Enterprises LLP (toy production/distribution) since Feb 2014
- Held a similar role at Robotrix Technologies LLP from Oct 2014 to Jun 2018
- Founder & Director of Profoods Nutrition Pvt Ltd since May 2020, overseeing repackaging and strategy
2. Ms. Parul Shailesh Mehta – Promoter & Selling Shareholder
- Co-owner of a significant promoter stake alongside Ankit.
3. Mr. Shailesh Vinodrai Mehta – Promoter
- A promoter with a minor shareholding position in the company
Why This Matters
- Leadership & Strategy: The promoters bring relevant domain knowledge—Ankit’s technical and entrepreneurial background supports chemical distribution and nutraceutical tech objectives.
- Governance & Skin-in-the-Game: Significant pre-IPO promoter holdings, along with mandated lock-ins, provide confidence in leadership alignment and long-term commitment.
Chemkart India Limited IPO Lot Size
Here’s the detailed information on the lot size for the Chemkart India Limited IPO:
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 600 | ₹1,48,800 |
| Retail (Max) | 2 | 1,200 | ₹2,97,600 |
| HNI (Min) | 3 | 1,800 | ₹4,46,400 |
Summary:
- You must apply in multiples of 600 shares.
- The minimum subscription is 2 lots (1,200 shares).
- This results in a minimum investment of approximately ₹2.83 lakh to ₹2.98 lakh, depending on the final bid price within the band.
Chemkart India Limited IPO Promoter Holding
Here are the details regarding the promoter holding for Chemkart India Limited around its upcoming IPO:
| Period | Promoter Group (%) | *Public Group (%) |
|---|---|---|
| Pre‑IPO | 100.00% | 0.00% |
| Post‑IPO | ~73.31% | ~26.69% |
Promoter Retention & Lock-In
- Post-IPO, the promoters will retain approximately 73.31% of the equity.
Per SEBI SME rules, at least 20% promoter holding is locked in for 3 years, with further lock-in of transferred shares: 50% for 2 years, and the remaining 50% for 1 year.
About Chemkart India Limited
- Founded: 21 April 2015, incorporated as Chemkart India Pvt Ltd in 2020, and converted to a public limited company in August 2024.
- Headquarters: Mumbai, Maharashtra.
- Facilities: A 28,259 sq ft processing, blending, grinding, packaging, and warehousing facility in Bhiwandi, Thane.
- Subsidiaries: Includes EZRM and Vinstar Biotech, with intent to add manufacturing capacity via Easy Raw Materials Pvt Ltd.
What It Does
- Business Model: A B2B distributor and processor of high-quality food and health ingredients sourced globally and provided to supplement, pharma, F&B, cosmetics, agriculture, animal nutrition, and textile sectors.
- Product Portfolio: Offers amino acids, vitamins, proteins, herbal extracts, nucleotides, sports nutrition ingredients, sweeteners, and more — with custom blending and packaging tailored to client needs.
- Certifications: Holds FSSAI; Halal (Global Accreditation Certification Board); Kosher (MQA); and ISO 9001:2015 quality‐management certification.
Summary
Chemkart is a rising B2B player in India’s nutraceutical and health-ingredient space — combining global sourcing, quality processing, and logistics efficiency, with a strong growth trajectory and clear strategic roadmap.
Chemkart India Limited Financial Information
Here’s the updated financial information for Chemkart India Limited, based on its updated prospectus and public disclosures:
| Period Ended | 31 Mar 2025 | Mar 31 2024 | 31 Mar 2023 |
| Assets | ₹86.12 Crore | ₹53.51 Crore | ₹37.48 Crore |
| Revenue | ₹205.46 Crore | ₹132.83 Crore | ₹131.69 Crore |
| Profit After Tax | ₹24.26 Crore | ₹14.52 Crore | ₹7.66 Crore |
| EBITDA | ₹32.76 Crore | ₹20.91 Crore | ₹11.05 Crore |
| Net Worth | ₹53.29 Crore | ₹29.01 Crore | ₹14.50 Crore |
| Reserves and Surplus | ₹43.79 Crore | ₹27.66 Crore | ₹13.14 Crore |
| Total Borrowing | ₹17.03 Crore | ₹12.55 Crore | ₹11.33 Crore |
Key Performance Indicator (KPI)
| KPI | Values |
|---|---|
| ROE | 59% |
| ROCE | 49% |
| Debt/Equity | 0.32 |
| RoNW | 45.52% |
| EBITDA Margin | 16.12% |
| Price to Book Value | 8.12 |
Interpretation of KPIs:
- High EPS & RoNW: Indicates solid profitability and efficient capital use.
- Healthy NAV: Reflects strong internal accruals and net worth growth.
- Low D/E Ratio: Suggests low leverage, reducing financial risk.
- Strong PAT/EBITDA Margins: Indicates good control over expenses and consistent profitability.
Objects of the Issue (Chemkart India Limited IPO Objectives)
| Purpose | Estimated Allocation (₹ Cr) | Details |
|---|---|---|
| ✅ Funding Capital Expenditure via Subsidiary (EZRM Pvt Ltd) | ₹34.77 Cr | To establish a new manufacturing facility under Easy Raw Materials Pvt Ltd, for producing nutraceuticals, food, and cosmetic ingredients. |
| ✅ Repayment or Prepayment of Certain Borrowings | ₹20.00 Cr | Reducing outstanding debt to improve debt-equity ratio and financial flexibility. |
| ✅ General Corporate Purposes | ₹9.84 Cr | Working capital, branding, marketing, operations, and expansion-related activities. |
| ✅ Public Issue Expenses | ₹2.00 Cr | Covering IPO-related costs including legal, registrar, lead manager, compliance fees, etc. |
Additional Notes
- The capital infusion into EZRM (Easy Raw Materials Pvt Ltd) marks a significant backward integration step — moving from just distribution to manufacturing.
- The debt repayment will help enhance net profitability and reduce interest costs, giving Chemkart a stronger post-IPO balance sheet.
- General corporate funds may support new product verticals, supply chain digitization, or team expansion in line with growth targets.
Strengths of Chemkart India Limited IPO
1) Diverse Product Portfolio
- Chemkart offers a wide range of nutraceutical, food, and health supplement ingredients like amino acids, vitamins, herbal extracts, and sports nutrition compounds, catering to multiple sectors including pharma, cosmetics, agriculture, and animal health.
2) In-house Processing Facility
- The company owns a well-equipped 28,259 sq. ft. facility in Bhiwandi that handles grinding, blending, repackaging, and labeling. This allows it to maintain consistent quality and hygiene standards across all offerings.
3) Strong Financial Growth
- Chemkart has shown significant growth in revenue and profit over the last three years, with healthy margins and strong return ratios. Its ROCE exceeds 45% and PAT margins have improved year-on-year.
4) Global Supplier Network
- The company imports high-quality raw materials from international suppliers and maintains flexibility to meet specific client requirements with custom blends and formulations.
5) Certified Quality Standards
- It is certified by FSSAI, ISO 9001:2015, Halal, and Kosher authorities, which adds credibility and makes it easier to work with major institutional buyers.
Risks of Chemkart India Limited IPO
1) Dependence on Imports
- A significant portion of raw materials are imported, primarily from China. This exposes Chemkart to foreign exchange fluctuations, shipping delays, and geopolitical risks.
2) No Exclusive Supply Agreements
- The company does not have long-term or exclusive contracts with its suppliers. Any disruption in supply or increase in prices could affect its margins and customer delivery timelines.
3) Negative Cash Flows in Past Periods
- In at least one recent financial year, the company reported negative operating cash flows, highlighting working capital strain despite profitability.
4) Highly Competitive Industry
- The nutraceutical and food ingredient market is crowded with local and global players. Pricing pressure, innovation demands, and regulatory changes may impact profitability.
5) Limited Operating History as Public Company
- Although it has been operating since 2015, it only converted into a public limited company in 2024. There may be a learning curve in governance, compliance, and investor relations.
Chemkart India Limited Contact Details
📍 Registered & Corporate Office
Chemkart India Limited
Office No. 403/404, 4th Floor, K.L. Accolade, 6th Road, TPS III,
Santacruz (East), Mumbai – 400 055, Maharashtra, India
CIN: U51220MH2020PLC338631
Incorporated: 6 March 2020
📞 General Inquiries
- Phone: +91 86554 19723 (Main)
- Sales Agent: +91 95886 994869
✉️ Email Contacts
- General / Sales: inquiry@chemkart.com
- Investor Relations: investors@chemkart.com
👥 Investor Grievances / Compliance
Ms. Ramdulari Saini
Company Secretary & Compliance Officer
- Phone: +91 91363 83828
- Email: investors@chemkart.com
📇 Registrar & Share Transfer Agent
Bigshare Services Pvt. Ltd.
- Address: S6‑2, 6th Floor, Pinnacle Business Park,
Mahakali Caves Road, Andheri (East), Mumbai – 400 093 - Phone: 022‑62638200
- Email: investor@bigshareonline.com
Meta Infotech Limited IPO Review: Date, Price, Lot & Details
Cryogenic OGS Limited IPO Review: Date, Price and Details
Disclaimer: The content on this website is intended for informational purposes only and should not be interpreted as financial or investment advice. Engaging in stock market activities involves inherent risks, and outcomes can be unpredictable. While we strive to provide accurate and up-to-date information, we do not make any guarantees regarding the completeness or reliability of the content. Any investment decisions you make should be based on your own research and consultation with a qualified financial professional. We are not responsible for any financial gains or losses resulting from actions taken based on the information provided here. Always invest wisely and at your own risk.
